Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic-Reference-Cited by-同舟云学术

Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic

Published:2021-04-01 Issue:4 Volume:181 Page:562
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Nguyen Thuy D.¹,Gupta Sumedha²,Ziedan Engy³,Simon Kosali I.⁴,Alexander G. Caleb⁵,Saloner Brendan⁶,Stein Bradley D.⁷

Affiliation:

1. Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor

2. Department of Economics, Indiana University-Purdue University Indianapolis

3. Department of Economics, Tulane University, New Orleans, Louisiana

4. O’Neill School Public and Environmental Affairs, Indiana University Bloomington

5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

6. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

7. RAND Corporation, Pittsburgh, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2774272/jamainternal_nguyen_2020_ld_200087_1617393595.57843.pdf

Reference5 articles.

1. How will COVID-19 affect the health care economy?;Cutler;JAMA,2020

2. Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment.;Stein;JAMA,2016

3. Ahmad? FB, Rossen? LM SP. Provisional drug overdose death counts. National Center for Health Statistics. Reviewed September 16, 2020. Accessed October 10, 2020. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

4. American Society of Addiction Medicine. Access to buprenorphine in office-based settings: ASAM COVID-19 Task Force Recommendations. Published 2020. Accessed October 10, 2020. https://www.asam.org/Quality-Science/covid-19-coronavirus/access-to-buprenorphine

5. Centers for Disease Control and Prevention. Data resources: analyzing opioid prescription data and oral morphine milligram equivalents (MME), 2018 version. Reviewed October 9, 2020. Accessed January 8, 2020. https://www.cdc.gov/drugoverdose/resources/data.html

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022;American Journal of Public Health;2024-07

2. Perceptions of stimulant and buprenorphine diversion and strategies to address it;Health Affairs Scholar;2024-05-30

3. Longitudinal trends in service utilisation of Alcohol and Other Drugs Services (AODS) during COVID-19: A Scoping Review;International Journal of Alcohol and Drug Research;2024-05-26

4. Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing;JAMA Network Open;2024-02-22

5. Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic Periods;Healthcare;2024-01-18